Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.
Pujade-Lauraine E, Brown J, Barnicle A, Wessen J, Lao-Sirieix P, Criscione SW, du Bois A, Lorusso D, Romero I, Petru E, Yoshida H, Vergote I, Colombo N, Hietanen S, Provansal M, Schmalfeldt B, Pignata S, Martín Lorente C, Berton D, Runnebaum IB, Ray-Coquard I.
Pujade-Lauraine E, et al. Among authors: hietanen s.
JCO Precis Oncol. 2023 Jan;7:e2200258. doi: 10.1200/PO.22.00258.
JCO Precis Oncol. 2023.
PMID: 36716415
Free PMC article.
Clinical Trial.